MedPath

DIAZEPAM INJECTION USP

DIAZEPAM INJECTION USP

Approved
DIN Number

00399728

Drug Class

Human

Market Date

Dec 31, 1980

Company
HC

Sandoz Canada, Inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number00399728
AIG Number0103614001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Targeted (CDSA IV)
A
ATC Code
N05BA01 DIAZEPAM
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous ,  Intramuscular
AHFS Classification28:24.08
Health Canada Classification

ACTIVE INGREDIENTS (1)

DIAZEPAMActive
Strength: 5 MG / ML
Monograph: DIAZEPAM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.